Protagenic Therapeutics, Inc. ( PTIX) - Key Metrics
PTIX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.53 | -$0.52 | -$0.52 |
| 2026Q1 | $0 | $2.81 | $0.15 | $0.14 |
| 2025Q4 | $0 | $1.14 | -$0.21 | -$0.21 |
| 2025Q3 | $0 | -$0.47 | -$0.81 | -$0.81 |
| 2025Q2 | $0 | -$1.37 | -$0.32 | -$0.32 |
PTIX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.18 |
| 2026Q1 | 0% | 0.06 |
| 2025Q4 | 0% | 0.29 |
| 2025Q3 | 0% | -1.82 |
| 2025Q2 | 0% | -0.67 |
PTIX
Price: $0.72
52 week price:
Earnings Per Share: -13.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6800
Market Capitalization: 1.4 million